EMVision Medical Devices Management
Management criteria checks 3/4
EMVision Medical Devices' CEO is Scott Kirkland, appointed in Jul 2023, has a tenure of 1.33 years. total yearly compensation is A$557.06K, comprised of 56.5% salary and 43.5% bonuses, including company stock and options. directly owns 5% of the company’s shares, worth A$8.06M. The average tenure of the management team and the board of directors is 2.8 years and 5.4 years respectively.
Key information
Scott Kirkland
Chief executive officer
AU$557.1k
Total compensation
| CEO salary percentage | 56.5% |
| CEO tenure | 1.3yrs |
| CEO ownership | 5.0% |
| Management average tenure | 2.8yrs |
| Board average tenure | 5.4yrs |
Recent management updates
Recent updates
EMVision Medical Devices (ASX:EMV) Is Using Debt Safely
Aug 28
Is EMVision Medical Devices (ASX:EMV) A Risky Investment?
Nov 21Here's Why We're Not At All Concerned With EMVision Medical Devices' (ASX:EMV) Cash Burn Situation
Apr 24EMVision Medical Devices Ltd's (ASX:EMV) CEO Compensation Is Looking A Bit Stretched At The Moment
Nov 09We're Not Very Worried About EMVision Medical Devices' (ASX:EMV) Cash Burn Rate
Oct 04Companies Like EMvision Medical Devices (ASX:EMV) Are In A Position To Invest In Growth
Jun 17We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Jan 07We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Oct 04We're Not Very Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Rate
Jun 08Here's Why We're Not Too Worried About EMvision Medical Devices' (ASX:EMV) Cash Burn Situation
Feb 22Investors Who Bought EMvision Medical Devices (ASX:EMV) Shares A Year Ago Are Now Up 319%
Dec 20
We Think EMvision Medical Devices (ASX:EMV) Can Afford To Drive Business Growth
Nov 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | AU$557k | AU$315k | -AU$3m |
| Mar 31 2024 | n/a | n/a | -AU$3m |
| Dec 31 2023 | n/a | n/a | -AU$3m |
| Sep 30 2023 | n/a | n/a | -AU$4m |
| Jun 30 2023 | AU$285k | AU$258k | -AU$4m |
| Mar 31 2023 | n/a | n/a | -AU$4m |
| Dec 31 2022 | n/a | n/a | -AU$5m |
| Sep 30 2022 | n/a | n/a | -AU$5m |
| Jun 30 2022 | AU$270k | AU$245k | -AU$6m |
| Mar 31 2022 | n/a | n/a | -AU$7m |
| Dec 31 2021 | n/a | n/a | -AU$7m |
| Sep 30 2021 | n/a | n/a | -AU$8m |
| Jun 30 2021 | AU$262k | AU$240k | -AU$8m |
| Mar 31 2021 | n/a | n/a | -AU$7m |
| Dec 31 2020 | n/a | n/a | -AU$5m |
| Sep 30 2020 | n/a | n/a | -AU$4m |
| Jun 30 2020 | AU$224k | AU$205k | -AU$3m |
| Mar 31 2020 | n/a | n/a | -AU$3m |
| Dec 31 2019 | n/a | n/a | -AU$3m |
| Sep 30 2019 | n/a | n/a | -AU$3m |
| Jun 30 2019 | AU$213k | AU$150k | -AU$3m |
| Mar 31 2019 | n/a | n/a | -AU$3m |
| Dec 31 2018 | AU$45k | AU$41k | -AU$2m |
Compensation vs Market: Scott's total compensation ($USD362.01K) is about average for companies of similar size in the Australian market ($USD297.98K).
Compensation vs Earnings: Scott's compensation has increased whilst the company is unprofitable.
CEO
Scott Kirkland
1.3yrs
Tenure
AU$557,063
Compensation
Mr. Scott Kirkland has been an Executive Director of EMvision Medical Devices Limited since July 11, 2017 and serves as its Chief Executive Officer and Managing Director since July 01, 2023. Mr. Kirkland h...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Executive Director | 1.3yrs | AU$557.06k | 5% A$ 8.1m | |
| CFO & Company Secretary | 7.3yrs | no data | 1.36% A$ 2.2m | |
| Chief Technology Officer | 1.8yrs | no data | no data | |
| Chairman of Clinical Advisory Board & Chief Scientific Officer | 3.9yrs | no data | 1.22% A$ 2.0m | |
| Head of Design | 3.8yrs | no data | no data | |
| Head of Tech Development | no data | no data | no data | |
| Head of Regulatory Affairs | 1.6yrs | no data | no data |
2.8yrs
Average Tenure
Experienced Management: EMV's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, MD & Executive Director | 7.3yrs | AU$557.06k | 5% A$ 8.1m | |
| Chairman of Clinical Advisory Board & Chief Scientific Officer | 5.4yrs | no data | 1.22% A$ 2.0m | |
| Ex-Officio Member of Clinical Advisory Board | 2.7yrs | no data | no data | |
| Independent Non-Executive Director | 4.2yrs | AU$55.50k | 0.056% A$ 89.5k | |
| Non-Executive Chairman | 6.7yrs | AU$105.45k | 2.42% A$ 3.9m | |
| Non-Executive Director | 6.7yrs | AU$55.50k | 1.0% A$ 1.6m | |
| Independent Non-Executive Director | 6.4yrs | AU$51.83k | 0.70% A$ 1.1m | |
| Member of Clinical Advisory Board | 5.4yrs | no data | no data | |
| Member of Clinical Advisory Board | 5.4yrs | no data | no data | |
| Member of Clinical Advisory Board | 5.4yrs | no data | no data | |
| Member of Clinical Advisory Board | 5.4yrs | no data | no data | |
| Ex-Officio Member of Clinical Advisory Board | 2.7yrs | no data | no data |
5.4yrs
Average Tenure
Experienced Board: EMV's board of directors are considered experienced (5.4 years average tenure).